News

Healthcare

Staff Reporter

, Singapore

Published:

1 year ago

268 views

(From left to right) Beh Kian Teik (Chief Executive, A*STAR), Dr Tan See Leng (Minister for Manpower and Second Minister for Trade and Industry), Soh Leng Wan (Assistant Managing Director (Manufacturing), Enterprise SG), Choo Heng Tong (Executive Vice President, EDB), Wong Anwei (Executive Director, Singapore Precision Engineering and Technology Association (SPETA)).

MedTech Catapult opens in Biopolis

It supports MedTech innovators in bringing products to market and connecting with local manufacturers.

MedTech Catapult, a national initiative led by A*STAR, has launched at Biopolis.

This $38m initiative, first announced during the Committee of Supply debate in March 2024, aims to accelerate the development and commercialisation of high-value life science instruments and medical devices.

“Through purposeful productisation, our national platforms such as MedTech Catapult guide MedTech innovations from ideation to regulatory approval and scalable manufacturing, ensuring they are market-ready,” said Irene Cheong, assistant chief executive (Innovation & Enterprise) at A*STAR.

In its first year, MedTech Catapult has supported projects such as Castomize’s Remouldable Orthopaedic Cast (4D-printed remouldable short arm cast for wrist fractures) and Dornier MedTech’s Smart System for Enhanced Laser Lithotripsy (kidney stone treatment).

In addition, MedTech Catapult unveiled a local supplier and contract manufacturer directory titled “Medtech Manufacturing in Singapore: A Commitment to Engineering Excellence.”

This directory, jointly supported by the Ministry of Trade and Industry, A*STAR, Enterprise Singapore (EnterpriseSG), the Singapore Economic Development Board, and the Singapore Precision Engineering and Technology Association, highlights the differentiated capabilities of local manufacturers.

It provides an overview of local capabilities, aiding medtech product owners to find potential local partners for co-innovation opportunities and scaling production efficiently. Additionally, it will be regularly updated to connect medtech innovators to the right manufacturing partners.

Follow the link for more news on

A*STAR

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.

If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Book a meeting

| Or download the media kit (PDF)

240,000 senior readers quarterly in print Top 1,700 Singapore companies reached

7 markets across Southeast Asia